Fu Sheng Wang - JoVE Visualize

Showing results (131-140 of 369) with videos related to

Pageof 37

Sort By:

Emerging Infectious Diseases|March 4, 2020

Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020Jiaye Liu, Xuejiao Liao, Shen Qian, et al.

Gut|October 31, 2022

Engineered anti-PDL1 with IFNα targets both immunoinhibitory and activating signals in the liver to break HBV immune toleranceChao-Yang Meng, Shiyu Sun, Yong Liang, et al.

Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 8, 2020

Longitudinal changes of liver function and hepatitis B reactivation in COVID-19 patients with pre-existing chronic hepatitis B virus infectionJiaye Liu, Tingyan Wang, Qingxian Cai, et al.

BMC Infectious Diseases|November 13, 2025

Significant histologic alterations in untreated chronic hepatitis B children: a meta-analysisChenyang Huang, Xin Guo, Ziwei Wang, et al.

Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|May 14, 2013

[A clinical and pathological analysis of 22 cases of primary sclerosing cholangitis]Hong-hong Liu, Jun-liang Fu, Sheng-qiang Luo, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|June 30, 2010

Increased turnover of FoxP3high regulatory T cells is associated with hyperactivation and disease progression of chronic HIV-1 infectionShaojun Xing, Junliang Fu, Zheng Zhang, et al.

Journal of Clinical and Translational Hepatology|January 16, 2023

MRI/PAI Dual-modal Imaging-guided Precise Tracking of Bone Marrow-derived Mesenchymal Stem Cells Labeled with Nanoparticles for Treating Liver CirrhosisFeng-Yong Liu, Ming Shi, Xin Li, et al.

Infectious Diseases & Immunity|June 22, 2026

Impact on clinical biomarkers, immune recovery, and HIV reservoir dynamics of switching to EVG/c/FTC/TAF versus maintaining a non-INSTI-based regimen in virologically suppressed individualsYi Zhang, Hui-Huang Huang, Bing Song, et al.

Zhonghua Yi Xue Za Zhi|July 31, 2003

[Identification of phenotype and Interferon-alpha-producing capability of circulating type II dendritic cells and its clinical implication in HBV-infected patients]Xue-zhang Duan, Fu-sheng Wang, Min Wang, et al.

Clinical Immunology (Orlando, Fla.)|June 21, 2005

Longitudinal alteration of circulating dendritic cell subsets and its correlation with steroid treatment in patients with severe acute respiratory syndromeZheng Zhang, Dongping Xu, Yonggang Li, et al.

Pageof 37

Showing results (131-140 of 369) with videos related to

Sort By:

Pageof 37

Emerging Infectious Diseases|March 4, 2020

Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020Jiaye Liu, Xuejiao Liao, Shen Qian, et al.

Gut|October 31, 2022

Engineered anti-PDL1 with IFNα targets both immunoinhibitory and activating signals in the liver to break HBV immune toleranceChao-Yang Meng, Shiyu Sun, Yong Liang, et al.

Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 8, 2020

Longitudinal changes of liver function and hepatitis B reactivation in COVID-19 patients with pre-existing chronic hepatitis B virus infectionJiaye Liu, Tingyan Wang, Qingxian Cai, et al.

BMC Infectious Diseases|November 13, 2025

Significant histologic alterations in untreated chronic hepatitis B children: a meta-analysisChenyang Huang, Xin Guo, Ziwei Wang, et al.

Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|May 14, 2013

[A clinical and pathological analysis of 22 cases of primary sclerosing cholangitis]Hong-hong Liu, Jun-liang Fu, Sheng-qiang Luo, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|June 30, 2010

Increased turnover of FoxP3high regulatory T cells is associated with hyperactivation and disease progression of chronic HIV-1 infectionShaojun Xing, Junliang Fu, Zheng Zhang, et al.

Journal of Clinical and Translational Hepatology|January 16, 2023

MRI/PAI Dual-modal Imaging-guided Precise Tracking of Bone Marrow-derived Mesenchymal Stem Cells Labeled with Nanoparticles for Treating Liver CirrhosisFeng-Yong Liu, Ming Shi, Xin Li, et al.

Infectious Diseases & Immunity|June 22, 2026

Impact on clinical biomarkers, immune recovery, and HIV reservoir dynamics of switching to EVG/c/FTC/TAF versus maintaining a non-INSTI-based regimen in virologically suppressed individualsYi Zhang, Hui-Huang Huang, Bing Song, et al.

Zhonghua Yi Xue Za Zhi|July 31, 2003

[Identification of phenotype and Interferon-alpha-producing capability of circulating type II dendritic cells and its clinical implication in HBV-infected patients]Xue-zhang Duan, Fu-sheng Wang, Min Wang, et al.

Clinical Immunology (Orlando, Fla.)|June 21, 2005

Longitudinal alteration of circulating dendritic cell subsets and its correlation with steroid treatment in patients with severe acute respiratory syndromeZheng Zhang, Dongping Xu, Yonggang Li, et al.

Pageof 37